Effect of Intravenous Infusion of Lidocaine on Patients Undergoing Radical Resection of Colorectal Tumors
Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
Colorectal cancer (CRC) is one of the most common malignant tumors in the world. Surgical
resection is the main treatment option for colorectal cancer patients. Surgery may enhance or
accelerate tumor recurrence and metastasis. Multiple factors in the tumor microenvironment
play important roles in tumor recurrence and metastasis, and modulating the tumor
microenvironment can inhibit disease progression. Lidocaine has been found to inhibit tumor
growth in animal experiments.